SAN FRANCISCO, California, July 5 -- PLOS Pathogens, a journal that says it focuses on understanding of pathogens and how they interact with host organisms, published research articles, including the following topics, in its June 2022 edition:

Reviews:

* Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19

* Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immun . . .

Click here for more information about our products